Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01786187 · ClinicalTrials.gov registry record · Phase 1

The Symptom Experience Study in Persons With Non-Small Cell Lung Cancer

A Phase 1 study, sponsored by Michigan State University.

Completed
Registry status
Phase 1
Development phase
87
Enrollment target

NCT01786187 is a Phase 1 study that has completed, run by Michigan State University. The registered enrollment target is 87 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01786187, a Phase 1 study, has completed, sponsored by Michigan State University.

COMPLETED
Registry status
Phase 1
Development phase
87 participants
Enrollment target

Study Summary

Little is known about the symptom experience of persons having undergone surgery for lung cancer. What we do know is that symptoms are common and can become severe and lasting. The main purpose of this study is two-fold: 1. To better understand the symptom experience of persons with lung cancer prior to surgery and for up to six weeks after returning home from the hospital. 2. To examine the role of a light physical activity program in persons who are undergoing surgery for lung cancer for the treatment of a specific symptom. The goals of this study include: * Collecting information about the participant's current and prior health history, symptoms, and health-related quality of life. * Assessing our ability to recruit participants to the study. * Assessing participant's level of participation. * Evaluating the participant's satisfaction with the program. We expect that patients after undergoing surgery for lung cancer during the recovery process will experience multiple symptoms. We also expect to find that a light intensity physical activity program will be feasible, acceptable, and show a positive impact on symptoms such as cancer-related fatigue and confidence for cancer-related fatigue self-management. Information gained from this randomized controlled trial study will be used to refine the design of future larger-scale studies targeting symptoms such as cancer-related fatigue for the lung cancer population.

Interventions

  • BEHAVIORAL Light Physical Activity
  • OTHER Symptom Experience Report

Trial Details

FieldValue
Enrollment Target 87 participants
Start Date 2013-01
Est. Completion 2014-10
Phase Phase 1

Sponsor

Michigan State University

120 total trials

What the Registry Record Tells You About NCT01786187

The ClinicalTrials.gov registry entry for NCT01786187 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 87 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Michigan State University, which has 120 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Light Physical Activity is the first listed.

NCT01786187 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01786187 about?

NCT01786187 is a clinical study titled "The Symptom Experience Study in Persons With Non-Small Cell Lung Cancer". Little is known about the symptom experience of persons having undergone surgery for lung cancer. What we do know is that symptoms are common and can become severe and lasting. The main purpose of this study is two-fold: 1. To better understand the symptom experience of persons with lung cancer pri...

What is the current status of trial NCT01786187?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 87 participants. The study started on 2013-01. Estimated completion is 2014-10.

What interventions are being tested in trial NCT01786187?

The interventions under investigation include: Light Physical Activity (BEHAVIORAL), Symptom Experience Report (OTHER).

Who is sponsoring clinical trial NCT01786187?

This trial is sponsored by Michigan State University, which has 120 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.